Oncology
From Chemo to Advanced Therapies: New Frontiers in Oncology
Serene Lee
Nice Insight
PAO-25-30-29Apr 15, 2025
LOGIC GATES
Boolean Biology: The Future of Logic-Gated Cell and Gene Therapies
David Alvaro, Ph.D.
Pharma's Almanac
PAO-03-25-NI-03Mar 14, 2025
Immuno-oncology
Immuno-Oncology at the Forefront of Cancer Medicine
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-10Mar 02, 2025
Bioassays
Developing a Toolbox of Functional Bioassays for Optimizing ADCC
Anke Hartung, Ph.D.,
Tanvex CDMO
PAO-09-24-CL-09Sep 30, 2024
Vaccines
Delivering a Next-Generation COVID-19 Vaccine for Immunocompromised Patients and Novel Cancer Vaccines
David Dodd; Mark Newman, Ph.D.
GeoVax Inc.
PAO-10-23-CL-07Nov 09, 2023
Cell Therapy
Engineering Immune Cells to Realize the Promise of Cancer Cell Therapies
Beau Webber, Ph.D.
Luminary Therapeutics
PAO-08-23-CL-04Sep 05, 2023
Immuno-Oncology
Targeted Immune System Activation: A Paradigm Shift in Immuno-oncology
Dan Passeri, M.Sc., J.D.
Cue Biopharma
PAO-12-022-CL-01Jan 04, 2023
CAR-T
Enabling Greater Patient Access to CAR-T Cell Therapies with Off-the-Shelf Delivery Solutions
Ryan Larson, Ph.D.
Umoja Biopharma
PAO-12-022-CL-04Jan 03, 2023
CAR-T and iPSC Platform Technologies
Umoja Biopharma Presents New Preclinical Data on its Integrated In Vivo CAR-T and Engineered iPSC Platform Technologies at the SITC 37th Annual Meeting
Umoja Biopharma
PR-M11-22-06Nov 11, 2022
Theranostics
Theranostic Manufacturing Solutions
Muctarr Sesay, Ph.D.
GBI
PAO-08-022-CL-07Aug 29, 2022
Cell Therapy
Targeting Cancers by Leveraging the Biology of Gamma Delta T Cells
Bryan Kobel
TC Biopharm
PAO-07-022-CL-03Aug 09, 2022
Immuno-Oncology
Tuning the Myeloid Compartment with a Best-in-Class CDMO
Kiren Khanduga; Alicia Levey, Ph.D.
Pionyr Immunotherapeutics
PAO-06-022-CL-04Jun 06, 2022
Cell Therapy
Fighting Solid Tumors by Targeting Neoantigens in a Personalized Manner
Mark Shlomchik, M.D., Ph.D.
BlueSphere Bio
PAO-06-022-CL-03Jun 06, 2022
Immuno-Oncology
Building Multiple Platforms to Address Difficult-to-Treat Cancers
Derek Hennecke
Inceptor Bio
PAO-05-22-R250-09May 24, 2022
Oncolytic Viruses
Coverting Viruses into Therapeutic Tools
OncoMyx Therapeutics
PAO-04-22-R250-14Apr 12, 2022
Phase I Trial
Anixa Biosciences Announces the Initiation of its Ovarian Cancer CAR-T Phase I Trial at Moffitt Cancer Center
Anixa Biosciences
PR-M03-22-17Mar 30, 2022
Anti-Cancer Therapeutic
“Amazing” Nanoparticles from Maize: A Potent and Economical Anti-Cancer Therapeutic
Tokyo University of Science
PR-M02-22-11Feb 14, 2022
Immunotherapy Research
Genetically Engineered Dual Receptor T-cells: Double Trouble for Cancer Cells
Juntendo University
PR-M01-22-23Jan 31, 2022
Biotech-CDMO Relationship
For mAbs, a Small Biotech Recognizes the Value in Lonza’s Expertise and Track Record
William Ben Jones, Ph.D.
Corvus Pharmaceuticals
PAO-09-21-CL-03Sep 08, 2021
Immuno-Oncology
Training the Immune System to Recognize Cancer Cells
Ian B. Walters, M.D., MBA
Portage Biotech, Inc.
PTV-07-21-CL-001-838Jul 08, 2021